Reiterating that COVID-19 vaccines must be recognized as public goods for the whole world, the World Health Organization (WHO) has said that all countries must contribute.
Addressing a press conference in Geneva, Switzerland Katherine O’Brien, director of WHO’s Department of Immunization, Vaccines, and Biologicals said that pathogens and germs can’t be prevented from crossing the borders which is why these vaccines have to be recognized as protecting the whole of the world and the contributions from every country to do that.
“Although one country may be able to vaccinate a high proportion of individuals, and in fact, even induce herd immunity in the country, the transmission of pathogens crosses borders,” she said, adding that everyone is at risk if any country is at risk.
Giving the example of measles O’Brien said that “measles anywhere is measles everywhere. And when we have measles anywhere, it means every country must continue to immunize and immunize at the rate that it does protect every individual in the community.”
China’s COVID-19 vaccine trial shows promising results
The race to develop the vaccine for the deadly infection, which has claimed the lives of 327,821 people, all over the world is on and recently The University of Oxford declared that researchers have begun recruiting adults and children for advanced human trials of a COVID-19 vaccine that will involve up to 10,260 volunteers across the United Kingdom.
According to a study published online by the medical journal The Lancet, China’s COVID-19 vaccine trial, the first such vaccine to reach phase 1 clinical trial, is safe, well-tolerated, and able to generate an immune response against the coronavirus in humans, reported Xinhua.
As per the report, the open-label trial in 108 adults demonstrates promising results after 28 days and the final results will be evaluated in six months. Further trials are required to tell whether the immune response it elicits effectively protects against SARS-COV-2 infection.
(With inputs from timesnownews)